Feed Articles

TSMC receives $6.6 billion subsidy for Arizona factory

The U.S. Department of Commerce has finalized a $6.6 billion government subsidy for Taiwan Semiconductor Manufacturing Co's U.S. subsidiary $TSM. This funding is part of a broader $52.7 billion program authorized in 2022 under the Chips and Science Act.

Manufacturing expansion and state-of-the-art technology

TSMC plans to use this grant to expand its investment in Phoenix, Arizona to a total of $65 billion. In addition to the existing factory, two more will be added, with the second starting to produce the most advanced 2nm chips as early as 2028. TSMC also announced that it will use its state-of-the-art "A16" manufacturing process in Arizona.

"When we started this project, many doubted that TSMC would produce high-end chips in the U.S.," said Commerce Secretary Gina Raimondo. "But in the end, they are bringing the most sophisticated technology to the U.S."

Terms of the subsidy and wider implications

In addition to direct financial support, the agreement with TSMC also includes favorable government loans of up to $5 billion. The company will draw down the subsidies in stages as project milestones are met, with a minimum of $1 billion expected to be received by the end of 2024.

As part of the deal, TSMC has committed to forgo share buybacks and share excess profits with the US government for five years.

TSMC CEO C.C. Wei said in a statement: "This agreement allows us to accelerate the development of the most advanced semiconductor technologies available in the United States."

Strategic importance to the U.S.

The passage of the Chip and Science Act in 2022 was intended to revive US semiconductor manufacturing, which has lagged in recent decades. The US currently lacks domestic production of high-end chips, which has been a key argument for attracting investment from companies such as TSMC.

Raimondo stressed that this project is crucial not only economically but also in terms of national security. "The market fails to appreciate the importance of national security. That's why we had to convince TSMC to invest, and at the same time ensure that U.S. companies will buy U.S.-made chips," she said.

Export restrictions and relations with China

Regulating exports of advanced technology is also part of the US strategy. According to Reuters, the Commerce Department has ordered TSMC to stop shipping advanced chips to China.

Raimondo did not directly confirm the move, but stressed the importance of defensive measures: "Investing in TSMC's U.S. expansion is an offensive - defense means ensuring that TSMC or any other company does not sell our most advanced technology to China and violate export rules."

The future of the U.S. semiconductor industry

In addition to TSMC, the US government supports other chipmakers. For example, Samsung received $6.4 billion to expand a plant in Texas, Intel $8.5 billion and Micron Technology $6.1 billion. These projects are key to ensuring US technological independence.

"This program is proof that with targeted support and strategic investment, it is possible to restore U.S. leadership in semiconductor manufacturing," Raimondo added.

Disclaimer: There is a lot of inspiration to be found on Bulios, but stock selection and portfolio construction is up to you, so always do a thorough analysis of your own.

Source: Yahoo Finance, Reuters.

Stocks mentioned

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 5h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy